Skip to main content

Site notifications

(Approval lapsed) AMILORIDE 5mg Tablets, 28 tablet blister pack

Section 19A approved medicine
(Approval lapsed) AMILORIDE 5mg Tablets, 28 tablet blister pack
Section 19A approval holder
HL Pharma Pty Ltd ABN 31 168 013 723
Phone
03 9823 6228
Approved until
Status
Expired
Medicines in short supply/unavailable
KALURIL amiloride hydrochloride dihydrate 5mg tablet bottle - ARTG 17652
Indication(s)

Potassium-conserving agent; diuretic.

Although Amiloride Hydrochloride may be used alone, its principal indication is as concurrent therapy with thiazides or more potent diuretics in order to conserve potassium during periods of vigorous diuresis and during long-term maintenance therapy.

In congestive heart failure, Amiloride Hydrochloride may be effective alone, but its principal indication is for concomitant use in patients receiving thiazides or more potent diuretic agents.

In hypertension, it is used as an adjunct to prolonged therapy with thiazides and similar agents to prevent potassium depletion.

In hepatic cirrhosis with ascites, Amiloride Hydrochloride usually provides adequate diuresis, with diminished potassium loss and less risk of metabolic alkalosis, when used alone. It may be used with more potent diuretics when a greater diuresis is required while maintaining a more balanced serum electrolyte pattern.

Help us improve the Therapeutic Goods Administration site